3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
3
Other hematologic neoplasm
2
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
76
Lymphoma
73
Lymphoma, Non-Hodgkin
66
Hodgkin Disease
53
Leukemia
40
Lymphoma, Large B-Cell, Diffuse
37
Multiple Myeloma
35
Myelodysplastic Syndromes
34
Lymphoma, Mantle-Cell
33
Leukemia, Myeloid, Acute
33
Leukemia, Lymphocytic, Chronic, B-Cell
30
Burkitt Lymphoma
30
Lymphoma, Follicular
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Lymphoma, B-Cell, Marginal Zone
17
Lymphoma, Large-Cell, Immunoblastic
15
Recurrence
12
Myeloproliferative Disorders
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Neoplasms, Plasma Cell
9
Hematologic Neoplasms
9
Dendritic Cell Sarcoma, Interdigitating
9
Lymphoma, T-Cell
8
Leukemia, Myelomonocytic, Chronic
8
Leukemia, Biphenotypic, Acute
8
Primary Myelofibrosis
7
Leukemia, Myelomonocytic, Juvenile
7
Blast Crisis
7
Waldenstrom Macroglobulinemia
6
Neoplasms
6
Interventions
Bortezomib
4
fludarabine
3
Lenalidomide
3
dacetuzumab
2
Tacrolimus
2
Dexamethasone
2
Alemtuzumab
2
plerixafor
1
ofatumumab
1
isatuximab
1
fludarabine phosphate
1
ficlatuzumab
1
epratuzumab
1
Whole-Body Irradiation
1
Vorinostat
1
Stem Cell Transplantation
1
Rifaximin
1
Mycophenolic Acid
1
KW-2478
1
Hsp90 inhibitor KU757
1
Granulocyte Colony-Stimulating Factor
1
Erlotinib Hydrochloride
1
Cyclophosphamide
1
Clonal Hematopoiesis
1
Chromatin Immunoprecipitation Sequencing
1
Calcium Dobesilate
1
CLR1404
1
Busulfan
1
Blood Cell Count
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Paraproteinemias
×
Granulocyte Colony-Stimulating Factor
×
Lymphoid
×
Clear all
NCT01186224
2025-03-17
PHANTASTIC
University of Liverpool
Phase NA
Completed
60 enrolled